HomeSPRINT • STO
add
Sprint Bioscience AB
Previous close
kr 0.69
Day range
kr 0.66 - kr 0.70
Year range
kr 0.36 - kr 2.07
Market cap
73.86M SEK
Avg Volume
129.26K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 13.91M | -16.69% |
Operating expense | 15.83M | 4.75% |
Net income | -7.37M | -27.45% |
Net profit margin | -53.00 | -53.00% |
Earnings per share | — | — |
EBITDA | -6.80M | -19.19% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 24.66M | -31.52% |
Total assets | 38.60M | -20.08% |
Total liabilities | 24.29M | -17.96% |
Total equity | 14.31M | — |
Shares outstanding | 105.52M | — |
Price to book | 4.94 | — |
Return on assets | -48.80% | — |
Return on capital | -197.05% | — |
Cash Flow
Net change in cash
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -7.37M | -27.45% |
Cash from operations | -12.18M | -232.75% |
Cash from investing | — | — |
Cash from financing | 18.05M | 8,123.56% |
Net change in cash | 5.87M | 251.08% |
Free cash flow | -9.65M | -414.45% |
About
Founded
2009
Website
Employees
36
